ATG16L1 Depletion-Mediated Activation of the TRAF1 Signaling in Macrophages Aggravates Liver Fibrosis

Overview

Journal Mediators Inflamm

Publisher Wiley

Specialties Biochemistry
Pathology

Date 2024 Dec 4

PMID 39629085

Authors

Yufeng Pan

Yi Wei

Xinyu Zhan

Qingfa Bu

Zibo Xu

Xiaozhang Xu

Qi Wang

Yuan Liang

Yue Yu

Haoming Zhou

Ling Lu

Affiliations

Soon will be listed here.

Abstract

Hepatic macrophages play an indispensable role in liver pathophysiology, serving as key orchestrators of both liver injury and repair processes. ATG16L1 (autophagy-related 16 like 1) has emerged as a novel and critical autophagy marker. In macrophages, ATG16L1 assumes a particularly crucial role. The current understanding of how macrophage ATG16L1 regulates liver inflammation in the context of liver fibrosis is unclear. This study included clinical patient samples of liver fibrosis and established a murine model with myeloid-specific knockout, creating a mouse model of liver fibrosis. Employing RNA sequencing, we sought to elucidate the mechanisms of macrophage ATG16L1 in liver fibrosis by identifying critical signaling pathways. To assess the influence of macrophage ATG16L1 on hepatocyte apoptosis and hepatic stellate cell (HSC) activation, we constructed a dedicated culture system. Ultimately, the introduction of mice with myeloid-specific knock-in substantiated the protective role of myeloid-specific against inflammatory signaling, hepatocyte apoptosis, and activation of HSCs. An upregulation of the ATG16L1 signal was observed in the liver tissues of patients with liver fibrosis and in fibrotic mice, predominantly localized to hepatic macrophages. In mice afflicted with liver fibrosis, we detected exacerbated liver damage, evidenced by heightened inflammatory signal expression, increased hepatocyte apoptosis, and enhanced activation of HSCs. The absence of macrophage was found to result in elevated TNF receptor-associated factor 1 (TRAF1) signaling, triggering inflammatory activation, intensifying hepatocyte apoptosis, and facilitating HSC activation through the transforming growth factor beta 1 (TGF-1) signaling. The detrimental effects of macrophage depletion were demonstrated to be mitigated upon reintroduction. This research delved into the mechanisms by which the macrophage ATG16L1 signal influences inflammatory signaling, hepatocyte apoptosis, and activation of HSCs in liver fibrosis. Consequently, it offers theoretical substantiation and an experimental groundwork for the identification of biological targets for therapeutic intervention in liver fibrosis.

References

Kanayama A, Seth R, Sun L, Ea C, Hong M, Shaito A . TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. Mol Cell. 2004; 15(4):535-48. DOI: 10.1016/j.molcel.2004.08.008. View

Li M, Wang Z, Zhang L, Zheng H, Liu D, Zhou M . Burden of Cirrhosis and Other Chronic Liver Diseases Caused by Specific Etiologies in China, 1990-2016: Findings from the Global Burden of Disease Study 2016. Biomed Environ Sci. 2020; 33(1):1-10. DOI: 10.3967/bes2020.001. View

Asrani S, Devarbhavi H, Eaton J, Kamath P . Burden of liver diseases in the world. J Hepatol. 2018; 70(1):151-171. DOI: 10.1016/j.jhep.2018.09.014. View

Zhang X, Shen J, Man K, Chu E, Yau T, Sung J . CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis. J Hepatol. 2014; 61(6):1365-75. DOI: 10.1016/j.jhep.2014.07.006. View

Hong R, Tan Y, Tian X, Huang Z, Wang J, Ni H . XIAP-mediated degradation of IFT88 disrupts HSC cilia to stimulate HSC activation and liver fibrosis. EMBO Rep. 2024; 25(3):1055-1074. PMC: 10933415. DOI: 10.1038/s44319-024-00092-y. View

Weber L, Boll M, Stampfl A . Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol. 2003; 33(2):105-36. DOI: 10.1080/713611034. View

Zigmond E, Samia-Grinberg S, Pasmanik-Chor M, Brazowski E, Shibolet O, Halpern Z . Infiltrating monocyte-derived macrophages and resident kupffer cells display different ontogeny and functions in acute liver injury. J Immunol. 2014; 193(1):344-53. DOI: 10.4049/jimmunol.1400574. View

Tan Z, Sun H, Xue T, Gan C, Liu H, Xie Y . Liver Fibrosis: Therapeutic Targets and Advances in Drug Therapy. Front Cell Dev Biol. 2021; 9:730176. PMC: 8490799. DOI: 10.3389/fcell.2021.730176. View

Tang X, Zhang L, Wei W . Roles of TRAFs in NF-κB signaling pathways mediated by BAFF. Immunol Lett. 2018; 196:113-118. DOI: 10.1016/j.imlet.2018.01.010. View

10.

Moon A, Singal A, Tapper E . Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis. Clin Gastroenterol Hepatol. 2019; 18(12):2650-2666. PMC: 7007353. DOI: 10.1016/j.cgh.2019.07.060. View

11.

Sun S, Ley S . New insights into NF-kappaB regulation and function. Trends Immunol. 2008; 29(10):469-78. PMC: 5751948. DOI: 10.1016/j.it.2008.07.003. View

12.

Lavorgna A, De Filippi R, Formisano S, Leonardi A . TNF receptor-associated factor 1 is a positive regulator of the NF-kappaB alternative pathway. Mol Immunol. 2009; 46(16):3278-82. DOI: 10.1016/j.molimm.2009.07.029. View

13.

Xie P . TRAF molecules in cell signaling and in human diseases. J Mol Signal. 2013; 8(1):7. PMC: 3697994. DOI: 10.1186/1750-2187-8-7. View

14.

Kisseleva T, Brenner D . Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 2020; 18(3):151-166. DOI: 10.1038/s41575-020-00372-7. View

15.

Zhang W, Chen S, Zhou S, Wu S, Wang H . Inflammasomes and Fibrosis. Front Immunol. 2021; 12:643149. PMC: 8226128. DOI: 10.3389/fimmu.2021.643149. View

16.

Friedman S . Liver fibrosis -- from bench to bedside. J Hepatol. 2003; 38 Suppl 1:S38-53. DOI: 10.1016/s0168-8278(02)00429-4. View

17.

Li D, Tong J, Li Y, Meng H, Ji Q, Zhang G . Melatonin safeguards against fatty liver by antagonizing TRAFs-mediated ASK1 deubiquitination and stabilization in a β-arrestin-1 dependent manner. J Pineal Res. 2019; 67(4):e12611. DOI: 10.1111/jpi.12611. View

18.

Zhang F, Wang H, Wang X, Jiang G, Liu H, Zhang G . TGF-β induces M2-like macrophage polarization via SNAIL-mediated suppression of a pro-inflammatory phenotype. Oncotarget. 2016; 7(32):52294-52306. PMC: 5239552. DOI: 10.18632/oncotarget.10561. View

19.

Aimaiti Y, Yusufukadier M, Li W, Tuerhongjiang T, Shadike A, Meiheriayi A . TGF-β1 signaling activates hepatic stellate cells through Notch pathway. Cytotechnology. 2019; 71(5):881-891. PMC: 6787120. DOI: 10.1007/s10616-019-00329-y. View

20.

Mizushima N, Komatsu M . Autophagy: renovation of cells and tissues. Cell. 2011; 147(4):728-41. DOI: 10.1016/j.cell.2011.10.026. View